Piramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet ...

Market Analysis For September 30 The Nifty Index opened the gap down by more than 100 points and cascaded throughout the day ...

Piramal's global Contract Development and Manufacturing Organization plans to more than double the facility’s capacity by Q1 ...

Stocks including NTPC, Tata Power, IRCTC, Blue Dart, Andhra Cements, Bank of Maharashtra, Piramal Pharma and more will be the ...

Gift Nifty is indicating a rebound in Sensex and Nifty after yesterday's fall. Around 7:20 AM, Gift traded firmly in the ...

Automobile stocks, such as Tata Motors Ltd., Eicher Motors Ltd. and Bajaj Auto Ltd. will be in focus as automobile companies ...

Indian benchmark indices Nifty 50 and Sensex ended the previous trade session lower. Nifty 50 ended at 25,810.85, while ...

GIFT Nifty ended 22 points or 0.08% down at 25,984.50 indicating a negative opening for domestic indices NSE Nifty 50 and BSE ...

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

U.P. Oncolytics, a company in Rosalind Franklin University's Helix 51 biomedical incubator, has earned an NIH fast-track grant for the development of a novel treatment for a deadly form of brain ...